Role of Serologic and Molecular Diagnostic Assays in Identification and Management of Hepatitis C Virus Infection

February 6, 2016 at 8:13 am

Journal of Clinical Microbiology February 2016 V.54 N.2 P.265-273

Gavin Cloherty, Andrew Talal, Kelly Coller, Corklin Steinhart, John Hackett Jr., George Dawson, Juergen Rockstroh, and Jordan Feld

aAbbott Diagnostics, Abbott Park, Illinois, USA

bUniversity at Buffalo, Buffalo, New York, USA

cViiV Healthcare, Research Triangle Park, North Carolina, USA

dUniversity Bonn, Bonn, Germany

eUniversity of Toronto, Toronto, Canada

The drugs available for the treatment of hepatitis C virus (HCV) have evolved to provide shorter treatment duration and higher rates of sustained virologic response (SVR), and the role of HCV infection diagnostic tests has had to evolve in order to meet changing clinical needs.

This review gives an overview on the role of HCV infection diagnostic testing (molecular and serological tools) used in the diagnosis and management of HCV infection.

All of this critical information guides physician decisions to optimize patient clinical outcomes. Also discussed is the future direction of diagnostic testing in the context of further advances in drug development.

abstract

http://jcm.asm.org/content/54/2/265.abstract?etoc

PDF

http://jcm.asm.org/content/54/2/265.full.pdf

Entry filed under: Antivirales no HIV, Biología Molecular, Hepatitis C, Infecciones virales, Metodos diagnosticos, REVIEWS, Update. Tags: .

Interim Guidelines for Health Care Providers Caring for Pregnant Women and Women of Reproductive Age with Possible Zika Virus Exposure — United States, 2016 High Prevalence of vanM in Vancomycin-Resistant Enterococcus faecium Isolates from Shanghai, China


Calendar

February 2016
M T W T F S S
« Jan   Mar »
1234567
891011121314
15161718192021
22232425262728
29  

Most Recent Posts


%d bloggers like this: